Photo Credit: Emory’s Goizueta Alzheimer’s Disease Research Center Website
In 2018, the D Jones Family Charitable Foundation contributed to Atlanta-based Emory’s Goizueta Alzheimer’s Disease Research Center (ADRC). According to its website, ADRC was founded in 2005 and is one of 27 active centers in the nation supported by the National Institutes of Health (NIH). The goal of these centers is to bring scientists together to facilitate their research and help learn more about Alzheimer’s and related diseases. ADRC is also committed to the education of health care professionals, persons with Alzheimer’s disease, their families, and the community to aid in understanding, diagnosis and treatment of these illnesses. Read More
Gamma Flicker Clinical Trials
This year’s gift went specifically to helping fund ADRC’s Gamma Flicker clinical trials. According to the NIH’s U.S. National Library of Medicine website trial summary, Alzheimer’s disease is characterized by the accumulation of toxic proteins in the brain. Mechanisms to remove these proteins have been the target of many drug trials. Emory’s Gamma Flicker study is designed to use a device to entrain brain waves to a specific frequency to see if rodent research can be replicated in humans with mild cognitive impairment. Ten participants will be recruited from the Emory Alzheimer’s Disease Research Center (ADRC) database and assigned to either treatment for 8 weeks or treatment for 4 weeks. This latter group will serve as the control group (4 weeks no treatment, 4 weeks treatment). It is hypothesized that exposure to the gamma oscillations (Flicker) will clear toxic proteins from the brain and increase cerebral blood flow. Read More